AI Article Synopsis
- A systematic review by the PATH program and Dalhousie Academic Detailing Service concluded that lipid-lowering therapy is not supported by evidence for severely frail elderly patients.
- The findings suggest that this treatment may not be beneficial for individuals in this specific age and health group.
- The research highlights the importance of tailoring medical interventions to the unique needs of severely frail elderly patients.
Article Abstract
After performing a systematic review, members of the Palliative and Therapeutic Harmonization (PATH) program and the Dalhousie Academic Detailing Service found that evidence does not support lipid-lowering therapy for severely frail elderly patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3949/ccjm.84a.15114 | DOI Listing |
Publication Analysis
Top Keywords
severely frail
8
frail elderly
8
elderly patients
8
patients lipid-lowering
4
lipid-lowering drugs
4
drugs performing
4
performing systematic
4
systematic review
4
review members
4
members palliative
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!